Sorry to be ignorant. This discussion regarding timeframe to market is interesting. Can I just ask, based on what I read above if it is reasonable to assume that if the clinical results of the trial were good and there were no safety concerns then a fast-track TGA approval would take an additional 13 - 24 months to achieve? (13 months being unusually fast and 24 months more like standard.)
Ann: Paradigm Receives $8.2m R&D Tax Incentive Refund, page-15
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.010(3.03%) |
Mkt cap ! $128.1M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.5¢ | 31.5¢ | $236.8K | 732.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 32801 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 25549 | 4 |
View Market Depth
| Last trade - 12.38pm 08/08/2025 (20 minute delay) ? |
| PAR (ASX) Chart |